Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Biotech a Priority in China’s $309 Billion Five-Year Plan

publication date: Jun 28, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China has earmarked 2 trillion RMB ($309 billion) for science and technology in its 2011-2015 Five-Year Plan. Biotechnology – including biopharmacy, bio-engineering, bio-agriculture and biomanufacturing – will be a major priority, according to Yandong Liu, Chinese State Councilor and member of the Politburo. The goal of the funding is two-fold: to improve the quality of life in China and to add one million new jobs by 2015. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors